Tag: Long-acting antipsychotic medication
Monthly Schizophrenia Therapy: Teva’s Safety Profile Highlighted
Teva Pharmaceuticals recently shared new safety data from the Phase III SOLARIS trial and a Phase I study regarding extended-release subcutaneous olanzapine, TEV-‘749. This...